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Abstract: Background: The changes in the period of ventricular repolarization, i.e., QT interval, QTp
(Q-Tpeak) and TpTe interval (Tpeak–Tend), make it possible to assess the electrical instability of
the heart muscle, which may lead to the development of life-threatening ventricular arrhythmia.
The aim of the study was to determine and evaluate the use of differences in T-wave morphology
and durations of repolarization period parameters (QT, TpTe) in resting ECGs for children with
ventricular arrhythmias. Methods: The retrospective analysis was made of the disease histories
of 80 examined children with resting ECGs, which were admitted to the Children’s Cardiology
Department. The study group consisted of 46 children aged 4 to 18 with ventricular arrhythmias and
the control group consisted of 34 healthy children between 4 and 18 years of age, with no arrhythmias.
Results: The duration of the TpTe interval was significantly (p < 0.001) longer in the group of children
with ventricular arrhythmia with abnormal T-wave (bactrian/bifid, humid/biphasic) compared to
the TpTe interval in children with ventricular arrhythmia with the normal repolarization period. The
duration of the TpTe (p < 0.001), QTcB (p < 0.001) and QTcF (p < 0.001) intervals were significantly
longer in the group of children with ventricular arrhythmias and with abnormal T-wave compared
to the values of the TpTe, QTcB, and QTcF intervals of the control group with normal morphology
of the repolarization period. Only the duration of the TpTe interval was significantly (p = 0.020)
longer in the group of children with ventricular arrhythmia without clinical symptoms. Conclusions:
Children with benign ventricular arrhythmias recorded on a standard ECG with prolonged TpTe and
QT intervals and abnormal T-wave morphology require systematic and frequent cardiac check up
with long term ECG recordings due to the possibility of future more severe ventricular arrhythmias.
Further follow-up studies in even larger groups of patients are necessary to confirm the values of
these repolarization parameters in clinical practice.
Keywords: children; electrocardiography; ventricular repolarization; ventricular arrhythmias; TpTe
interval
1. Introduction
Arrhythmias are an important clinical problem in the developmental population and
a common cause of hospitalization. Their clinical course is most often asymptomatic, with
no tangible cardiovascular abnormalities. Among the healthy population, premature ven-
tricular beats in the standard ECG may be recorded in 0.3–2.2% of newborns, infants, and
children with normal circulatory system [1]. About 50% of children and adolescents with
mild ventricular arrhythmias (spontaneously disappearing in about 48–65% of children),
arrhythmia is of unknown etiology without coexisting overt, organic, or primarily electro-
physiological heart disease [2]. The severity of ventricular arrhythmias can be manifested
in chest pain, rapid heartbeat, dizziness, blurred vision (‘darkness’ in front of the eyes),
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fainting and loss of consciousness, and sudden cardiac arrest [3–6]. The analysis of resting
electrocardiographic and/or 24 h ECG by Holter’s method is necessary in the diagnosis
of arrhythmias as a cause of syncope, circulatory failure, as well as in the assessment of
the risk of sudden cardiac death [7–10]. Electrocardiographic parameters of the repolariza-
tion period: QT interval, QTp (Q-Tpeak), and especially the TpTe interval (Tpeak–Tend),
which is the final part of the T-wave, is an indicator of electrical myocardial instability
(heterogeneity of repolarization), the increase of which, with the change of the wave shape
T (bactrian/bifid, humid/biphasic) may predispose to life-threatening arrhythmias. In the
literature the TpTe interval seems to be a more sensitive indicator of arrhythmogenesis
compared to the standard QT interval [1,11–14]. The aim of the study was to determine
in the standard ECG electrocardiographic values of repolarization period parameters, i.e.,
the TpTe interval (Tpeak–Tend) and QT interval, corrected Bazett (QTcB) and Fridericia
(QTcF) formulas with the assessment of T-wave morphology in a group of children with
ventricular arrhythmias and in children in the control group, as well as the assessment of
the possibility of using differences in T-wave morphology and durations of repolarization
period parameters (QT, TpTe) determined in the standard ECG in the examined groups of
children in predicting the risk of a more serious arrhythmia.
2. Materials and Methods
The retrospective analysis was carried out on the histories of examined children
with electrocardiographic records (12-lead ECG), which were performed after each of the
children was admitted to the Children’s Cardiology Department. The information included
in the medical records of younger children (physical and family history) was obtained from
their parents or legal guardians.
2.1. The Studied Subjects
A group of 80 children were included in the study. The study group consisted of
46 children (21 girls and 25 boys) aged 4 to 18 years (average age 13 ± 6 years) with
ventricular arrhythmias of unknown etiology which were recorded in standard ECG in
12 children (26%) or in 24 h Holter ECG monitoring in 34 children (74%).
The control group consisted of 34 healthy children (volunteers) (22 girls and 12 boys)
aged 4 to 18 years (average age 13 ± 3 years) without confirmed arrhythmias. All the
children from the study group and the control group were hospitalized in the Children’s
Cardiology Department of the Independent Public Clinical Hospital No. 6 of the Silesian
Medical University in Katowice—Ligota (Upper Silesian Children’s Health Centre of John
Paul II).
None of the 80 children had a positive sudden cardiac death or structural heart disease
in physical examination and in echocardiography using the Doppler method as well as no
arrhythmias during exercise stress (Bruce protocol).
Inclusion criteria in the group of examined children: ventricular arrhythmias in
standard ECG and in the 24 h ECG Holter method, the history of arrhythmia diagnosed,
normal physical examination result apart from periodically irregular heart rhythm, without
signs of infection or structural features of the heart defect, negative family history regarding
structural and electrophysiological abnormalities of the heart, episodes of sudden cardiac
death in the child’s relatives before 30 years of age (sudden infant deaths, drowning,
car accidents in unexplained circumstances), normal echocardiographic result, correct
laboratory results excluding the presence of inflammation and ionic disorders (K, Ca, Mg).
Criteria for inclusion in the control group: no history of complaints suggesting cardiac
arrhythmias with no cardiac arrhythmias on the ECG and the 24 h ECG Holter method,
negative family history regarding structural and electrophysiological abnormalities of the
heart, no episodes of sudden cardiac death in relatives of a child before 30 years of age,
correct physical examination result, with particular emphasis on the state of the circulatory
system, without signs of inflammation or structural features of the heart defect with normal
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echocardiographic result, correct laboratory results excluding the presence of inflammation
and ionic disorders (K, Ca, Mg).
Exclusion criteria for testing: extra-sinus rhythm on the standard ECG and 24 h Holter
ECG, features of sick sinus syndrome, atrioventricular and intraventricular conduction
disorders in the right and left branches of the bundle in standard ECG and the 24 h
Holter ECG recording, diagnosis of structural heart defect (including cardiomyopathies),
inflammation of the heart muscle, abnormal electrolyte levels in blood laboratory tests (K,
Ca, Mg), the use of drugs that change the repolarization period, the presence of diseases that
change the repolarization period (connective tissue diseases, neurological and endocrine
diseases), lack of consent of the patient or their legal guardian.
Electrocardiography
Standard ECG recordings were performed in the supine position using the recorder
model AT2 plus Schiller AG. Baar, Switzerland. Measurements were made manually in
the fifth pre-cardiac lead (V5) in 12-lead ECGs. The analysed measurements were the
average of three consecutive QRS-T evolutions at a paper travel of 50 mm/s and a standard
feature amplitude of 1 mV = 1 cm. The analysis of the repolarization period evaluated the
duration of individual repolarization parameters as well as the amplitude and shape of the
T-wave (bactrian/bifid, humid/biphasic). From three consecutive QRS-T evolutions, RR
intervals, total repolarization duration—QT interval, and TpTe interval (TpeakTend) were
determined and recorded enlarged with a magnifying glass using a distance stepper. The
total QT repolarization period was determined from the beginning of the Q wave to the
end of the T-wave, defined as the place of return of the descending arm of the T-wave to
the isoelectric line excluding U wave. The period of late repolarization TpTe (TpeakTend)
was calculated from the top of the T-wave to the end of the T-wave [15,16]. The corrected
duration of the QT interval in relation to the heart rate (QTcB) was calculated according
to the Bazett formula (QT/
√
RR) and Fridericia (QT/RR1/3) [17,18]. In the case of two T-
waves peaks, the first peak of the T-wave was taken into account in measurements [19–21].
All measurements were analyzed blindly by two independent investigators with uniformity
testing without access to results obtained and clinical data. The highest quality ECGs were
analyzed without network disturbances with exclusion flat T-wave.
2.2. Statistical Analysis
The statistical analysis is based on statistical inference as a consequence of hypothesis
verification. In the analysis the significant level was assumed to be 0.05. We verify
the hypotheses according to the obtained p-value (“p” for short) for a statistical test. If
the p-value is greater than or equal to 0.05, then there is no reason to reject the null
hypothesis at a significance level of 0.05, which usually says that there are no statistically
significant differences. When the p-value is less than 0.05, we reject the null hypothesis at
the significance level of 0.05 and conclude that there are statistically significant differences.
Both parametric and non-parametric hypotheses were considered in the analysis. Most
often, non-parametric hypotheses are applied when the assumption that the distribution
of the examined feature is normal is not met. For each considered feature in all studied
populations, the normality of the distribution was checked using the Shapiro–Wilk test.
Depending on the obtained results, a parametric or non-parametric test was used. In
the case of comparing two independent samples, the parametric Student’s t-test or the
non-parametric Mann–Whitney U test was used.
The results of the statistical tests are presented in the tables. In the case of parametric
tests, the following were given: arithmetic mean and standard deviation calculated for the
considered samples (groups of children), as well as the number of samples (row N) and
the name of the test used together with the p-value. In the case of non-parametric tests,
the following were given: the sum of ranks and the mean of the ranks obtained for the
considered samples (groups of children), as well as the sample size (row N) and the name
of the test used together with the p-value.
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The boxplots were also used in the presentation of the results. From such charts one
can read the basic measures of descriptive statistics. And more specifically: the median—
the horizontal line in the middle of the box, the first quartile—the lower base of the box,
the third quartile—the top of the box, the minimum–the level of the lower whisker, the
maximum—the level of the upper whisker.
The calculations and the graphs used in the article were made in the Statistica software
(version 13.1, StatSoft, TIBCO Software Inc., Palo Alto, California, United States).
2.3. Ethical Approval
The research project was approved by the Bioethical Committee of the Medical Uni-
versity of Silesia in Katowice in 2015, No. KNW/0022/KB/238/15.
3. Results
In children with a history of ventricular arrhythmia, the most commonly reported
clinical manifestations were poor exercise tolerance (n = 8, 36.4%), stabbing chest pain
(n = 5, 22.7%), chest twinge (n = 5, 22.7%) and fainting (n = 4, 18.2%). There were no
complaints in the control group of healthy children (Table 1). In the 12-lead ECG per-
formed at admission, 12 (27%) children with ventricular arrhythmia had single premature
ventricular beats (ventricular extrasystoles) (Table 1). In 22% of children with ventricular
arrhythmia, abnormal T-waves in lead V4, V5, and V6 were observed in the standard ECG:
bactrian/bifid T-waves in five children (11%) and humid/biphasic T-waves in five children
(11%) (Table 1).
Table 1. The summary of clinical observations of children with ventricular arrhythmias and healthy









Age (median) 13.4 13.6 13.3
Female, n (%) 43 (53.7%) 21 (46%) 22 (65%)
Male, n (%) 37 (46.3%) 25 (54%) 12 (35%)
Complaints
Palpitations, n (%) 2 (2.5%) 2 (9.1%) 0
Chest twinge, n (%) 5 (6.2%) 5 (22.7%) 0
Chest pain, n (%) 1 (1.2%) 1 (4.5%) 0
Fainting, n (%) 4 (5%) 4 (18.2%) 0
Worse exercise tolerance, n (%) 8 (10%) 8 (36.4%) 0
Syncope, n (%) 5 (6.2%) 5 (22.7%) 0
Headache and dizziness, n (%) 2 (2.5%) 2 (9.1%) 0
Feeling of irregular heart-beat,
n (%) 1 (1.2%) 1 (4.5%) 0
Ventricular extrasystoles
in ECG, n (%) 12 (15%) 12 (26%) 0
T-wave morphology
Bactrian, n (%) 5 (6.2%) 5 (11%) 0
Humid, n (%) 5 (6.2%) 5 (11%) 0
All ventricular extrasystoles originated from the left ventricle (with right bundle
branch block (RBBB) morphology).
Due to the number of registered extrasystoles in 24 h Holter ECG monitoring, 4 subgroups
were distinguished in the entire study group: (1) less than 1000 a day, (2) 1000–10,000 per
day, (3) over 10,000 a day, (4) recorded tachycardia.
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In the group of children with ventricular arrhythmia, the most frequently (n = 39, 85%)
that children recorded extrasystoles was in the number of 1000 to more than 10,000 per day
(Table 2).
Table 2. Characteristics of the study group with regard to extrasystoles in 24 h Holter ECG monitoring.
Number of Extrasystoles Children with VentricularArrhythmias (n = 46)
Control Group of Healthy
Children (n = 34)
Less than 1000 a Day 7 (15.26%) 0
1000–10,000 per Day 19 (41.30%) 0
Over 10,000 a Day 20 (43.44%) 0
Tachycardia 0 0
Total 46 (100%) 0
Single/complex beats 22 (47.82%)/8 (17.34%) 0
Of all the compared repolarization parameters, only the duration of the TpTe interval
was significantly (p = 0.033) longer in the group of children with ventricular arrhythmia
with an abnormal T-wave (bactrian, humid) relative to the TpTe interval in children with
ventricular arrhythmia with the normal repolarization period (Tables 3 and 4, Figures 1–5).
Table 3. The characteristics of QT, QTp, and TpTe intervals in the group of children with ventricular
arrhythmia depending on the T-wave morphology.




T-Wave Normal T-Wave Abnormal
N 36 10
Parameter
[ms] Sum of Ranks
Mean
of Ranks Sum of Ranks
Mean
of Ranks
QT 824.0 22.9 257.0 25.7 0.562
QTp 844.5 23.5 236.5 23.7 0.978
TpTe 775.5 21.5 305.5 30.6 0.033
Table 4. The characteristics of QTcB and QTcF intervals in the group of children with arrhythmia
ventricular depending on the T-wave morphology.
Children with Ventricular Arrhythmias
Student’s t-Test
p-Value








QTcB 409.1 24.9 423.1 28.3 0.134
QTcF 394.9 16.9 405.7 21.4 0.097
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The duration of the TpTe (p < 0.001), QTcB (p < 0.001) and QTcF (p < 0.001) intervals
were significantly longer in the group of children with ventricular arrhythmias and with
T-wave abnormal (bactrian, humid/biphasic) compared to the values of the TpTe, QTcB,
and QTcF intervals of the control group with normal morphology of the repolarization
period (Tables 5 and 6, Figures 6–10).
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Compared to the duration of the QT, QTp, QTcB, QTcF, and TpTe intervals, only the
duration of the TpTe interval was significantly (p = 0.020) longer in the group of children
with ventricular arrhythmia without clinical symptoms (Tables 7 and 8, Figures 11–15).
Table 7. The interval between QT, QTp, and TpTe in the group of children with ventricular arrhythmia with clinical
symptoms and without them.
Children with Ventricular Arrhythmias
Mann-Whitney U Test
p-Value
Children with Clinical Symptoms Children without Clinical Symptoms
N 28 18
Parameter [ms] Sum of Ranks Mean of Ranks Sum of Ranks Mean of Ranks
QT 678.5 24.2 402.5 22.4 0.653
QTp 708.5 25.3 372.5 20.7 0.260
TpTe 554.5 19.8 526.5 29.3 0.020
Table 8. The interval between QTcB and QTcF in the group of children with ventricular arrhythmia with clinical symptoms
and without them.
Children with Ventricular Arrhythmias
Student’s t-Test
p-Value
Children with Clinical Symptoms Children without Clinical Symptoms
N 28 18
Parameter [ms] Mean StandardDeviation Mean
Standard
Deviation
QTcB 410.6 27.1 414.6 24.8 0.615
QTcF 396.8 19.3 397.9 17.0 0.850
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orded in Standard ECG  
Ventricular Extrasystoles Rec-
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Figure 15. QTcF parameter in the group of children with ventricular arrhythmia with clinical symptoms and without them.
The duration of the TpTe (p < 0.001) interval was significantly longer in the group
of 26% children with ventricular extrasystoles recorded on standard ECG compared to
the value of the TpTe interval in the rest of children with ventricular arrhythmias on 24 h
Holter ECG monitoring. Similarly, the number of ventricular extrasystoles also in bigemini
and trigemini form was significantly higher in the children with ventricular arr ythmias
recorded on standard ECG then in the rest of study group with v ntricular arrhythmias
(Table 9).
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Table 9. The characteristics of TpTe interval in the group of children with ventricular extrasystoles recorded in standard
ECG from the children group with ventricular arrhythmias recorded in 24 h Holter ECG monitoring.
Children with Ventricular Arrhythmias
Mann-Whitney U Test
p-Value
Ventricular Extrasystoles Recorded in
Standard ECG
Ventricular Extrasystoles Recorded in
Holter ECG
N 12 34
Parameter Sum of Ranks Mean of Ranks Sum of Ranks Mean of Ranks
TpTe [ms] 410.0 34.2 671.0 19.7 <0.001
Number of extrasystoles
recorded in 24-h Holter ECG 360.0 30.0 721.0 21.2 0.035
4. Discussion
In our own study of 46 children with ventricular arrhythmias the most commonly
reported clinical manifestations were poor exercise tolerance (36.4%), stinging pain in the
chest (22.7%), chest twinge (22.7%), fainting (18.2%), and palpitations in 9.1% of children.
Similarly, in the studies by West et al. in 219 children with ventricular arrhythmia without
clinically concomitant overt heart disease, chest pain (9%), palpitations (7%), and syncope
(3%) were the most commonly reported, and at other authors’ in a group of 59 children the
feeling of irregular heartbeat prevailed (13.6%) [22,23]. The importance of careful collection
of anamneses of children with ventricular arrhythmia is confirmed by the study by Harris
et al. in which 82% of children with ventricular arrhythmia reported no symptoms, but
46% of patients in the surveyed group asked again about specific symptoms confirmed
their occurrence [24]. In our study the average age of the study group, 13 ± 6 years, was
the highest compared to the average age of children in the reports cited above, which
could explain the discrepancy in the frequency of the reported arrhythmia symptoms. The
younger age of the examined patients with difficulties in describing the ailments may be
important in perceiving and interpreting symptoms which is why it is so important to
complete the interview with the parents and carers of sick children. In our study only the
duration of the analyzed TpTe interval was significant in children with clinical symptoms
from those in asymptomatic patients in the group of children with ventricular arrhythmia.
Similarly, in the Cetin et al. it is reported that in the course of psoriasis with abnormal
electrocardiogram there were significant differences in the duration of the TpTe interval
when comparing patients with reported symptoms to asymptomatic ones [25].
In our own research 22% of the children with ventricular arrhythmia observed in
precordial ECG leads (V4–V6) abnormal T-waves (bactrian/bifid or humid/biphasic) with
a significantly prolonged duration of the TpTe interval compared to the TpTe value in
children with ventricular arrhythmia and normal period repolarization and with a pro-
longed duration in relation to the TpTe, QTcB, and QTcF values in children in the control
group. The presence of abnormal T-waves with prolonged TpTe interval, a diagnostic
indicator of arrhythmogenesis [26], burdens examined patients with the possibility of
life-threatening ventricular arrhythmia [27,28]. Abnormal T-waves are a characteristic
morphological disorder of the repolarization period in the prolonged QT syndrome (LQTS).
In 66–88% of carriers of the LQTS2 genotype the T-wave in the V4–V6 lead is most of-
ten flat and/or bifid [29], with 6% of symptomatic children with LQTS and 12–30% of
asymptomatic carriers, the duration of the QT interval may be normal, below 440 ms [30].
Lehmann et al. in a study involving 254 patients from 13 families diagnosed with LQTS
found a two-humped T-wave ECG in 53% of subjects with prolonged QT interval duration
(QTc > 470 ms) in 27% of patients with QTc from 420 to 460 ms and in 5% of patients with
normal QT interval (QTc < 410 ms) [31]. Malfatto et al., in 53 patients with LQTS, registered
biphasic T-waves in 62% of patients while in the 53-person control group biphasic T-waves
were present in 15% of patients [32]. Morphological analysis of abnormal T-waves with QT
and TpTe interval analysis may be helpful in identifying patients at increased risk of severe
ventricular arrhythmia leading to syncope and sudden cardiac death [27].
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The increased duration of the QT repolarization period, especially its final phase, from
the top to the end of the 262 T-wave TpTe interval is associated with an increased risk of
symptomatic ventricular arrhythmias [33–38].
In the study of Wolk et al., in 6 out of 13 adult patients with induced ventricular
arrhythmia the duration of the TpTe interval was longer compared to the TpTe interval of
7 patients without provoked arrhythmia [39]. Similarly, studies by Lubiński et al. found
a longer duration of the TpTe interval in 18 patients with ischemic heart disease and
recorded ventricular tachycardia compared to 16 patients who had a myocardial infarction
without ventricular arrhythmia [40]. Lubiński et al. (7 patients with LQTS vs 10 healthy
patients) and Viitasalo et al. (59 patients with LQTS vs 31 health patients) reported a
significantly longer TpTe interval in patients with arrhythmogenic long QT syndrome
(LQTS) compared to healthy patients [41,42]. Topilski et al. found an increased risk of
polymorphic ventricular tachycardia (TdP) in patients with prolonged TpTe and QTcB
intervals, especially those associated with bipolar T-waves in the course of acquired LQTS
syndrome due to bradyarrhythmia [28]. Yamaguchi et al. (12 patients with LQTS and TdP
vs 15 patients with LQTS without TdP) showed a longer TpTe interval in patients with
LQTS with polymorphic ’torsade de pointes’ compared to patients with LQTS without
registered TdP tachycardia [27]. Shimizu et al. found that the prolonged duration of the
TpTe interval, more than the QTc interval, predicts sudden cardiac death in patients with
hypertrophic cardiomyopathy [43].
The evaluation of repolarization period parameters, especially the TpTe interval, is
useful in identifying patients at high risk of serious cardiac arrhythmias also in other
clinical conditions such as short QT syndrome [44], long QT syndrome (LQTS) [45], hyper-
tension [46,47], arrhythmogenic right ventricular cardiomyopathy [48], and in competitive
sports [49]. The results of our own research are comparable to the opinions of many authors
talking about the desirability of assessment in a 12-lead ECG, not only of the duration
of the QT interval, but also the TpTe interval of the recognized new arrhythmogenesis
index, which is considered a more sensitive prognostic parameter of ventricular arrhythmia
compared to the one traditionally determined by QT interval [40–42].
The above studies of the parameters of the repolarization period were experimental
or carried out in adult patients, there are few studies in children.
In our study the duration of the TpTe, QTcF and QTcB interval was significantly longer
in children with ventricular arrhythmia compared to the values of these parameters in the
healthy children from the control group.
Additionaly, in 22% of the study group with ventricular arrhythmia, abnormal T-waves
with prolonged duration of the TpTe interval compared to the TpTe value in children with
ventricular arrhythmia and normal T-wave were observed. Moreover, recording of benign
ventricular arrhythmias in the standard ECG in 26% of examined children with an increased
number of extrasystoles also in form of bigemini and trigemini on Holter ECG, and above
all with a significant prolongation of TpTe interval with a potential pro-arrhytmic effect,
may be a useful prognostic tool in assessing the risk of serious and even life-threatening
arrhythmias in the future.
These are novel findings in children with ventricular arrhythmias of unknown etiology
with the analysis of parameters of the repolarization period and no similar data have been
found in available literature to date.
On the basis of our work, we wanted to show how important it is in everyday clinical
practice to determine the parameters of the repolarization period in the ECG standard,
especially in children with diagnosed ventricular arrhythmia because detected prolongation
of the TpTe and QT intervals with the abnormal T-wave morphology on a standard ECG
may be useful for identifying children more predisposed to severe ventricular arrhythmias
in the future.
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5. Conclusions
Children with benign ventricular arrhythmias recorded on a standard ECG with
prolonged TpTe and QT intervals and abnormal T wave morphology require systematic
and frequent cardiac check up with long term ECG recordings due to the possibility of
future more severe ventricular arrhythmias. Further follow-up studies in even larger
groups of patients are necessary to confirm the values of these repolarization parameters
in clinical practice.
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